Impact of low infliximab dose regimen on treatment response and drug survival in 462 patients with psoriatic arthritis. Results from the nationwide registries DANBIO and ICEBIO

Bente Glintborg; B. Gudbjornsson; N.S. Krogh; E. Omerovic; N. Manilo; M. Holland-Fischer; H.M. Lindegaard; A.G Loft; H. Nordin; L. Johnsen; S.F. Oeftiger; A. Hansen; C. Rasmussen; G. Grondal; A. Geirsson; Merete Lund Hetland

Impact of low infliximab dose regimen on treatment response and drug survival in 462 patients with psoriatic arthritis. Results from the nationwide registries DANBIO and ICEBIO

Bente Glintborg
, B. Gudbjornsson
, N.S. Krogh
, E. Omerovic
, N. Manilo
, M. Holland-Fischer
, H.M. Lindegaard
, A.G Loft
, H. Nordin
, L. Johnsen
, S.F. Oeftiger
, A. Hansen
, C. Rasmussen
, G. Grondal
, A. Geirsson
, Merete Lund Hetland

Department for Rheumatology and Spine Diseases

Original language	English
Journal	Arthritis & Rheumatism
Volume	65
Issue number	Suppl. 10
Pages (from-to)	S133-4
Number of pages	2
ISSN	0004-3591
Publication status	Published - 2013

Cite this

Glintborg, B., Gudbjornsson, B., Krogh, N. S., Omerovic, E., Manilo, N., Holland-Fischer, M., Lindegaard, H. M., Loft, A. G., Nordin, H., Johnsen, L., Oeftiger, S. F., Hansen, A., Rasmussen, C., Grondal, G., Geirsson, A., & Hetland, M. L. (2013). Impact of low infliximab dose regimen on treatment response and drug survival in 462 patients with psoriatic arthritis. Results from the nationwide registries DANBIO and ICEBIO. Arthritis & Rheumatism, 65(Suppl. 10), S133-4.

Impact of low infliximab dose regimen on treatment response and drug survival in 462 patients with psoriatic arthritis. Results from the nationwide registries DANBIO and ICEBIO. / Glintborg, Bente; Gudbjornsson, B.; Krogh, N.S. et al.
In: Arthritis & Rheumatism, Vol. 65, No. Suppl. 10, 2013, p. S133-4.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Glintborg, B, Gudbjornsson, B, Krogh, NS, Omerovic, E, Manilo, N, Holland-Fischer, M, Lindegaard, HM, Loft, AG, Nordin, H, Johnsen, L, Oeftiger, SF, Hansen, A, Rasmussen, C, Grondal, G, Geirsson, A & Hetland, ML 2013, 'Impact of low infliximab dose regimen on treatment response and drug survival in 462 patients with psoriatic arthritis. Results from the nationwide registries DANBIO and ICEBIO', Arthritis & Rheumatism, vol. 65, no. Suppl. 10, pp. S133-4.

@article{924514e17f104eb1bf6a1703dc3c3bfc,

title = "Impact of low infliximab dose regimen on treatment response and drug survival in 462 patients with psoriatic arthritis. Results from the nationwide registries DANBIO and ICEBIO",

author = "Bente Glintborg and B. Gudbjornsson and N.S. Krogh and E. Omerovic and N. Manilo and M. Holland-Fischer and H.M. Lindegaard and A.G Loft and H. Nordin and L. Johnsen and S.F. Oeftiger and A. Hansen and C. Rasmussen and G. Grondal and A. Geirsson and Hetland, \{Merete Lund\}",

year = "2013",

language = "English",

volume = "65",

pages = "S133--4",

journal = "Arthritis \& Rheumatism",

issn = "0004-3591",

publisher = "John Wiley \& Sons Inc.",

number = "Suppl. 10",

}

TY - ABST

T1 - Impact of low infliximab dose regimen on treatment response and drug survival in 462 patients with psoriatic arthritis. Results from the nationwide registries DANBIO and ICEBIO

AU - Glintborg, Bente

AU - Gudbjornsson, B.

AU - Krogh, N.S.

AU - Omerovic, E.

AU - Manilo, N.

AU - Holland-Fischer, M.

AU - Lindegaard, H.M.

AU - Loft, A.G

AU - Nordin, H.

AU - Johnsen, L.

AU - Oeftiger, S.F.

AU - Hansen, A.

AU - Rasmussen, C.

AU - Grondal, G.

AU - Geirsson, A.

AU - Hetland, Merete Lund

PY - 2013

Y1 - 2013

M3 - Conference abstract in journal

SN - 0004-3591

VL - 65

SP - S133-4

JO - Arthritis & Rheumatism

JF - Arthritis & Rheumatism

IS - Suppl. 10

ER -